Alcon Inc (ALC) stock
ALCNYSEOphthalmic GoodsFiscal year ends December 31
$73.64−0.48 (-0.65%)
Close on Nov 16, 2026Market cap $35.89BP/E 37.2Yield –
Alcon r&d expenses
Research and development expenses are spending on new products and technology.
Alcon's R&D Expenses for the twelve months ending Dec 31, 2010 was $747.00M, up 12.3% year over year. For fiscal 2025 it was $990.00M, up 13.0% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $990.00M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $990.00M | +13.0% |
| FY2024 | Dec 31, 2024 | $876.00M | +5.8% |
| FY2023 | Dec 31, 2023 | $828.00M | +17.9% |
| FY2022 | Dec 31, 2022 | $702.00M | -16.6% |
| FY2021 | Dec 31, 2021 | $842.00M | +25.1% |
| FY2020 | Dec 31, 2020 | $673.00M | +2.6% |
| FY2019 | Dec 31, 2019 | $656.00M | +11.8% |
| FY2018 | Dec 31, 2018 | $587.00M | +0.5% |
| FY2017 | Dec 31, 2017 | $584.00M | -21.8% |
| FY2010 | Dec 31, 2010 | $747.00M | +12.3% |
| FY2009 | Dec 31, 2009 | $665.00M | +7.4% |
| FY2008 | Dec 31, 2008 | $619.00M | +9.8% |
| FY2007 | Dec 31, 2007 | $564.00M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $663.00M | +266.3% |
| Q2 FY2025 | Jun 30, 2025 | $245.00M | +37.6% |
| Q2 FY2024 | Jun 30, 2024 | $220.00M | +35.0% |
| Q2 FY2023 | Jun 30, 2023 | $217.00M | +29.9% |
| Q2 FY2022 | Jun 30, 2022 | $181.00M | +19.1% |
| Q2 FY2021 | Jun 30, 2021 | $178.00M | -15.2% |
| Q2 FY2020 | Jun 30, 2020 | $163.00M | -11.4% |
| Q2 FY2019 | Jun 30, 2019 | $167.00M | -9.2% |
| Q2 FY2018 | Jun 30, 2018 | $152.00M | -10.1% |
| Q4 FY2010 | Dec 31, 2010 | $210.00M | +2.9% |
| Q3 FY2010 | Sep 30, 2010 | $184.00M | +16.5% |
| Q2 FY2010 | Jun 30, 2010 | $184.00M | +17.2% |
| Q1 FY2010 | Mar 31, 2010 | $169.00M | +15.8% |
| Q4 FY2009 | Dec 31, 2009 | $204.00M | +29.1% |
| Q3 FY2009 | Sep 30, 2009 | $158.00M | -9.2% |
| Q2 FY2009 | Jun 30, 2009 | $157.00M | +10.6% |
| Q1 FY2009 | Mar 31, 2009 | $146.00M | – |
| Q4 FY2008 | Dec 31, 2008 | $158.00M | – |
| Q3 FY2008 | Sep 30, 2008 | $174.00M | – |
| Q2 FY2008 | Jun 30, 2008 | $142.00M | – |
See a number that looks wrong?